// App-Quantinova.ai

Mo2022 : DEVELOPMENT AND FIRST INTERNATIONAL VALIDATION AND CHARACTERIZATION OF COLONIC IBD LESIONS: ADVANCED CHROMOENDOSCOPY IBD LESIONS: FACILE GROUP

Researchers

Presenter

  • Kenneth McQuaid

Principal Investigators

  • Toshio Uraoka

  • Takayuki Matsumoto

  • Silvia Sanduleanu

  • Yasushi Iwao

  • mark W Lowerison

  • Brendan C. Lethebe

  • Venkataraman Subramanian

  • Subrata Ghosh

  • Ralf Kiesslich

Medical Centers

  • University of California, Davis, Davis, California, United States

  • University of Birmingham ,UK, BIRMINGHAM, United Kingdom

  • University Hospital Maastricht, Maastricht, Netherlands

  • University of Leeds, Leeds, United Kingdom

  • Helios HSK, Wiesbaden, Germany

  • University of Calgary, Calgary, AB, Canada

  • University of Keio, Tokyo, Japan

  • University of Morioka, Iwate, Japan

Locations

  • Canada

  • Japan

  • Netherlands

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • 3β-hydroxysterol Δ24-reductase

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved